Search clinical trials for: Intravenous Immune Globulin (IVIG)

Total 416 results

Kanecia Obie Zimmerman

Enrolling by invitation

RECOVER-AUTONOMIC Platform Protocol (RECOVER-AUTO)

Long COVID | Long Covid19 | Long Covid-19

United States
Baxalta now part of Shire

Completed

A Study of Immune Globulin Subcutaneous (Human), 20% Solution (IGSC, 20%) in Japanese Participants With Primary Immunodeficiency Diseases (PID)

Primary Immunodeficiency Diseases (PID)

Japan
Anders Perner
CSL Behring

Completed

Immunoglobulin for Necrotizing Soft Tissue Infections: a Randomised Controlled Trial (INSTINCT)

Fournier Gangrene | Necrotizing Soft Tissue Infection | Necrotizing Fasciitis | Gas Gangrene

Denmark
University of California, San Diego
Patient-Centered Outcomes Research Institute

Completed

KIDCARE (Kawasaki Disease Comparative Effectiveness Trial) (KIDCARE)

Mucocutaneous Lymph Node Syndrome

United States
Loma Linda University

Terminated

Intravenous Immune Globulin (IVIG) Treatment Protocol in Kidney Transplant Patients

End Stage Renal Disease
George Sakoulas, MD
Octapharma

Completed

Study of SOC Plus IVIG Compared to SOC Alone in the Treatment of COVID-19

Sars-CoV2

United States
University of Tennessee

Completed

Human Immune Globulin in Treating Patients With Primary Amyloidosis That is Causing Heart Dysfunction

Multiple Myeloma | Plasma Cell Neoplasm

United States
Dow University of Health Sciences
Higher Education Commission (Pakistan)

Recruiting

Anti COVID 19 Hyperimmune Intravenous Immunoglobulin (C-IVIG) Therapy for Severe COVID-19 Patients

Covid19

Pakistan
Ottawa Hospital Research Institute
CSL Behring; Grifols Biologicals, LLC

Completed

Ig PRx in AECOPD: Pilot Study

Chronic Obstructive Pulmonary Disease

Canada
Grifols Therapeutics LLC

Completed

A Trial of the Pharmacokinetics, Safety, and Tolerability of Subcutaneous Gamunex® in Primary Immunodeficiency

Immunologic Deficiency Syndrome

United States, Canada
University of Texas

Terminated

Randomized Study of Intravenous Immunoglobulin in Patients With Mild or Moderate Myasthenia Gravis

Myasthenia Gravis
Rutgers, The State University of New Jersey

Recruiting

Immunoglobulin G Therapy Dose Optimization

Obesity | Immune Deficiency

United States
Baxalta now part of Shire

Completed

Comparison of Intravenous and Subcutaneous Administration of IGIV, 10% in Primary Immunodeficiency (PID) Subjects

Primary Immunodeficiency Diseases (PID)

United States
Emory University

Terminated

Randomized Study of Plasmapheresis or Human Immunoglobulin Infusion in Childhood Guillain-Barre Syndrome

Guillain-Barre Syndrome
National Center for Research Resources (NCRR)
University of Vermont

Completed

Phase III Multicenter Double Blind Controlled Trial of Human Immune Globulin Therapy in Previously Untreated Patients With Chronic Inflammatory Demyelinating Neuropathy

Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
National Center for Research Resources (NCRR)
Ohio State University

Completed

Phase III Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Immune Globulin for Chronic Inflammatory Demyelinating Polyneuropathy

Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
National Institute of Allergy and Infectious Diseases...

Terminated

Improving Transplant Options of Highly Sensitized Recipients Using IGIV-C, 10%

Kidney Failure, Chronic

United States
Biopharma Plasma LLC

Recruiting

Intravenous Immunoglobulin (IVIG, Bioven) Efficacy and Safety in Chronic Primary Immune Thrombocytopenia (ITP) in Adults

Primary Immune Thrombocytopenia

Ukraine
IWK Health Centre

Completed

Intravenous Pertussis Immune Globulin in Patients With Severe Childhood Pertussis Infection

Pertussis | Whooping Cough
National Institute of Neurological Disorders and...
Mayo Clinic

Completed

Phase III Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Immune Globulin for Multiple Sclerosis

Multiple Sclerosis
National Human Genome Research Institute (NHGRI)

Completed

Intravenous Immune Globulin to Treat Hereditary Inclusion Body Myopathy

Hereditary Inclusion Body Myopathy

United States
Mayo Clinic

Terminated

Randomized Study of Intravenous Immunoglobulin (IVIg) in Patients With Subacute Proximal Diabetic Neuropathy

Diabetic Neuropathies
National Institute of Allergy and Infectious Diseases...

Withdrawn

Vaccinia Immune Globulin in Treating or Preventing Vaccinal Infection

Communicable Diseases | Healthy
California Department of Health Services

Completed

Study of Human Botulism Immunoglobulin in Infants With Botulism

Botulism | Infant Botulism

United States
Baxalta now part of Shire

Completed

Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders

Primary Immunodeficiency Diseases (PID) | Immune Thrombocytopenic Purpura (ITP) | Kawasaki Syndrome

United States
Biotest Pharmaceuticals Corporation

Completed

Civacir® Polyclonal Immune Globulin (IgG) to Prevent Hepatitis C Virus (HCV) Recurrence in Liver Transplant Patients.

Liver Cirrhosis | Hepatitis, Viral, Human | Hepatocellular Carcinoma | Hepatitis C Infection | Viruses

United States
University of California, San Diego
Centocor, Inc.

Completed

Infliximab (Remicade) for Patients With Acute Kawasaki Disease

Kawasaki Disease

United States
Grifols Therapeutics LLC

Completed

Anti-Hepatitis A Virus, Pharmacokinetics, and Safety of Immune Globulin (Human) (GamaSTAN)

Anti-Hepatitis A Antibody Levels in Heathy Subjects

United States
National Institutes of Health Clinical Center (CC)

Completed

Plasmapheresis of Anthrax-Vaccinated Subjects for Production of Anthrax Immune Globulin

Anthrax

United States
Nabi Biopharmaceuticals

Completed

Safety and Behavior of S. Aureus Immune Globulin Intravenous(Human), [Altastaph] in Patients With S. Aureus Bacteremia and Continuing Fever

Staphylococcal Infections
Emory University
Georgia Institute of Technology

Terminated

Non-invasive Vagus Nerve Stimulation (nVNS) in Pediatric Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Chronic Inflammatory Demyelinating Polyneuropathy

United States
Emergent BioSolutions
Centers for Disease Control and Prevention

Enrolling by invitation

VA-005 Clinical Outcomes of VIGIV Treatment of Smallpox Vaccination Complications or Vaccinia Infection

Complication of Smallpox Vaccination
Instituto Grifols, S.A.

Completed

Study to Evaluate the Safety and Efficacy of High Dose IVIG in Hospitalized Participants With Coronavirus Disease (COVID-19)

COVID-19

Spain
Deepa Manwani

Recruiting

Intravenous Gammaglobulin for Sickle Cell Pain Crises

Pain | Sickle Cell Disease

United States
Baxalta now part of Shire

Completed

Gammagard Liquid and rHuPH20 in PID

Primary Immunodeficiency Diseases (PID)

United States, Canada
FFF Enterprises
OMRIX Biopharmaceuticals

Completed

A Clinical Study of Intravenous Immunoglobulin (IGIV)

Immunologic Deficiency Syndromes

United States, Canada
CSL Behring

Completed

Follow-up Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy (Japan Study)

Primary Immune Deficiency Disorder

Japan
Baxalta now part of Shire

Completed

Phase 2/3 Study of IGSC, 20% in PIDD

Primary Immunodeficiency Diseases (PID)

United States, Canada
Children's Hospital of Fudan University
Shanghai Children's Hospital; Shanghai Children's Medical Center

Completed

Different Doses of IVIG for Kawasaki Disease

Kawasaki Disease

China
Biotest
Syneos Health

Completed

Study to Investigate Efficacy, Safety and Pharmacokinetics of BT595 in Subjects With PID

Primary Immunodeficiency Disease

United States, Germany, Hungary, Russian Federation, Spain
Green Cross Corporation
Parexel; Atlantic Research Group

Completed

Study of Immune Globulin Intravenous (Human) GC5107 in Subjects With Primary Humoral Immunodeficiency

Immunologic Deficiency Syndromes

Canada, United States
Rennes University Hospital

Completed

Gammaglobulins Level is Predictive Factor of Evolution in Sarcoidosis (GAMES)

Sarcoidosis

France
National Institute of Neurological Disorders and...

Completed

Intravenousimmunoglobulin (IVIg) for the Treatment of Inflammatory Myopathies

Dermatomyositis | Polymyositis | Inclusion Body Myositis

United States
Queen Saovabha Memorial Institute

Completed

Human Rabies Immunoglobulin (HRIG)- Dosage Determination and Interference With the Active Immune Response

Rabies

Thailand
Instituto Grifols, S.A.

Completed

Efficacy and Safety of Niuliva® for the Prevention of Hepatitis B Virus Recurrence in Newly Orthotopic Liver Transplant Recipients

Liver Transplantation | Hepatitis B

Italy
CSL Behring

Completed

Multicenter Study of Long-Term Clinical Outcomes of Subcutaneous Immune Globulin IgPro20 in Subjects With Primary Immunodeficiency (Japan Study)

Primary Immune Deficiency

Japan
Nabi Biopharmaceuticals

Completed

Safety Study of an Intravenous Staphylococcus Aureus Immune Globulin (Human), [Altastaph] in Low-Birth-Weight-Neonates

Staphylococcal Infections
ADMA Biologics, Inc.

Completed

Open Label, Phase III Study of NABI-IGIV 10% [Immune Globulin Intravenous(Human), 10%] In Subjects With Primary Immune Deficiency Disorders (PIDD)

Primary Immune Deficiency Disorders (PIDD)

United States
University of South Florida
CSL Behring

Completed

Subcutaneous Immunoglobulin for CIDP (SCIG)

Chronic Inflammatory Demyelinating Polyneuropathy

United States
Green Cross Corporation
Atlantic Research Group

Recruiting

Study of Immune Globulin Intravenous (Human) GC5107 in Pediatric Subjects With Primary Humoral Immunodeficiency

Primary Immune Deficiency

United States

Search clinical trials for: Intravenous Immune Globulin (IVIG)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Slovakia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations